224 related articles for article (PubMed ID: 25059341)
21. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
22. Psoriasis and cardiovascular disease risk factors: the HUNT Study, Norway.
Snekvik I; Nilsen TIL; Romundstad PR; Saunes M
J Eur Acad Dermatol Venereol; 2018 May; 32(5):776-782. PubMed ID: 29397035
[TBL] [Abstract][Full Text] [Related]
23. Psoriasis Severity and Cardiometabolic Risk Factors in a Representative US National Study.
Lin IC; Heck JE; Chen L; Feldman SR
Am J Clin Dermatol; 2021 Sep; 22(5):719-730. PubMed ID: 33913115
[TBL] [Abstract][Full Text] [Related]
24. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments.
Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chaweekulrat P
J Dermatol; 2016 Dec; 43(12):1424-1428. PubMed ID: 27511608
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing cardiometabolic risk profile in patients with psoriasis.
Curcó N; Barriendos N; Barahona MJ; Arteaga C; García M; Yordanov S; De La Barrera O; Prat C; Vives P; Giménez N
Australas J Dermatol; 2018 May; 59(2):e93-e98. PubMed ID: 28240341
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study.
Teklu M; Zhou W; Kapoor P; Patel N; Dey AK; Sorokin AV; Manyak GA; Teague HL; Erb-Alvarez JA; Sajja A; Abdelrahman KM; Reddy AS; Uceda DE; Lateef SS; Shanbhag SM; Scott C; Prakash N; Svirydava M; Parel P; Rodante JA; Keel A; Siegel EL; Chen MY; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
J Am Acad Dermatol; 2021 May; 84(5):1329-1338. PubMed ID: 33383084
[TBL] [Abstract][Full Text] [Related]
28. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort.
Danielsen K; Olsen AO; Wilsgaard T; Furberg AS
Br J Dermatol; 2013 Jun; 168(6):1303-10. PubMed ID: 23374051
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Diseases and Associated Complications in Patients with Psoriasis.
Bajaj S; Mandal S; Singh KG; Prajapati R
J Assoc Physicians India; 2020 Oct; 68(10):44-46. PubMed ID: 32978925
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of metabolic syndrome in Montenegrin patients with psoriasis.
Ražnatović-Đurović M; Janković J; Janković S
Vojnosanit Pregl; 2016 Nov; 73(11):1016-21. PubMed ID: 29328640
[TBL] [Abstract][Full Text] [Related]
31. Association Between Pediatric Psoriasis and Waist-to-Height Ratio in the Absence of Obesity: A Multicenter Australian Study.
Lee A; Smith SD; Hong E; Garnett S; Fischer G
JAMA Dermatol; 2016 Dec; 152(12):1314-1319. PubMed ID: 27681388
[TBL] [Abstract][Full Text] [Related]
32. Facial involvement in Indian psoriatic patients and its association with disease severity and metabolic syndrome: A cross-sectional study.
Ranugha PSS; Bishnoi P; Chandrashekar L
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):522-527. PubMed ID: 31317874
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.
Kothiwala SK; Khanna N; Tandon N; Naik N; Sharma VK; Sharma S; Sreenivas V
Indian J Dermatol Venereol Leprol; 2016; 82(5):510-8. PubMed ID: 27297282
[TBL] [Abstract][Full Text] [Related]
34. Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway.
Modalsli EH; Åsvold BO; Romundstad PR; Langhammer A; Hoff M; Forsmo S; Naldi L; Saunes M
Br J Dermatol; 2017 May; 176(5):1162-1169. PubMed ID: 27718508
[TBL] [Abstract][Full Text] [Related]
35. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis.
Bostoen J; Van Praet L; Brochez L; Mielants H; Lambert J
J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):507-11. PubMed ID: 24772493
[TBL] [Abstract][Full Text] [Related]
36. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of cardiovascular risk factors in patients with psoriasis.
Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
[TBL] [Abstract][Full Text] [Related]
38. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
[TBL] [Abstract][Full Text] [Related]
39. Comorbidities and cardiovascular risk factors in patients with psoriasis.
Baeta IG; Bittencourt FV; Gontijo B; Goulart EM
An Bras Dermatol; 2014; 89(5):735-44. PubMed ID: 25184912
[TBL] [Abstract][Full Text] [Related]
40. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study.
Moebus S; Balijepalli C; Lösch C; Göres L; von Stritzky B; Bramlage P; Wasem J; Jöckel KH
Cardiovasc Diabetol; 2010 Aug; 9():34. PubMed ID: 20696055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
